Tech Company Financing Transactions
Terrestrial Bio Funding Round
On 3/26/2026, Terrestrial Bio secured $50 million in Series C financing from RA Capital, Engine Ventures and Global Health Investment Corporation.
Transaction Overview
Company Name
Announced On
3/26/2026
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Investors
RA Capital (Lead Investor) (Mario Barro)
Proceeds Purpose
With its new funding, the company has signed a lease with King Street Properties for a new manufacturing facility at Allston Labworks.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Cummings Park Dr.
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Overview
Terrestrial imagines a needle-free, refrigeration-free future of administering therapeutics -- from the comfort of your home, or anywhere you go. Our Mission: Mapping a future where anyone can benefit from next-gen therapies in a convenient, patient-friendly way. We are a group of life scientists, engineers, and entrepreneurs challenging ourselves and others to create breakthrough biomedical innovation, and make it available to people everywhere.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/26/2026: Tazapay venture capital transaction
Next: 3/26/2026: Conntour venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








